Search clinical trials for: Nexavar tab

Total 4954 results

Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Tigermed Consulting Co., Ltd

Completed

Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma

HCC

China
University of Pennsylvania

Completed

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Metastatic Medullary Thyroid Cancer | Metastatic Differentiated Thyroid Cancer | Metastatic Anaplastic Thyroid Cancer | Metastatic Poorly Differentiated Thyroid Cancer

United States
Centro di Riferimento Oncologico - Aviano

Terminated

Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma (SERCC)

Metastatic Renal Cell Carcinoma

Italy
University of Massachusetts, Worcester
National Institute of Mental Health (NIMH); Oregon Social Learning Center; Connecticut... and other collaborators

Completed

Multisystemic Therapy-Emerging Adults Trial (MST-EA)

Antisocial Behavior

United States
University of Wisconsin, Madison
Bayer

Completed

Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
National Cancer Institute (NCI)

Completed

Sorafenib and TRC105 in Hepatocellular Cancer

Carcinoma, Hepatocellular | Liver Neoplasms | Hepatoma | Adenoma, Liver Cell | Liver Neoplasms, Experimental

United States
Bayer

Completed

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

Carcinoma, Renal Cell

Japan
Bayer

Completed

Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China (SUCCESS)

Carcinoma, Hepatocellular

China
Bayer

Completed

Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting (NEXST)

Carcinoma, Renal Cell

Poland
Bayer

Completed

Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

United States, Canada
Bayer
Amgen

Completed

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Cancer | Carcinoma, Non-Small Cell Lung

United States, Germany
Chinese Society of Lung Cancer

Completed

Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

Non-Small Cell Lung Cancer

China
Bayer

Completed

Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

Carcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)

Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
Universidad Nacional Andres Bello

Completed

Effect of Omega 3 as an Immunomodulator Adjunct to Periodontal Debridement

Periodontitis

Chile
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

HIV Infections
University of Bern

Completed

Improve: Integrating Emotion Focused Components Into Psychological Therapy (Improve)

Unipolar Depression | Adjustment Disorder | Anxiety Disorder

Switzerland
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Effectiveness of VIRTUAL FIBROWALK STUDY

Fibromyalgia

Spain
IlDong Pharmaceutical Co Ltd

Completed

Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Mixed Dyslipidemias

Korea, Republic of
UNC Lineberger Comprehensive Cancer Center

Completed

Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases (TAD)

Breast Cancer

United States
Ain Shams University

Completed

Transversus Abdominis Plane Block for Post-operative Analgesia Following Cesarean Section

Analgesia

Egypt
University of Minnesota

Completed

Mindfulness, Group Therapy and Psychosis; Training Decreases Anxiety and Depression

Psychosis
Neurocrine Biosciences
Takeda

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants

Healthy

United States
Hospital Universitari Vall d'Hebron Research Institute

Active, not recruiting

Effectiveness of VIRTUAL SFCAMINA STUDY (SFCAMINA)

Chronic Fatigue Syndrome

Spain
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention

Drug Use Disorders

United States
Ain Shams University

Not yet recruiting

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Lupus Nephritis

Egypt
AJU Pharm Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Hypertension

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee

Osteoarthritis of Knee

Korea, Republic of
Ohio State University Comprehensive Cancer Center
Bayer

Terminated

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Celgene

Terminated

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

Carcinoma, Hepatocellular

United States
University of Pittsburgh
Bayer

Terminated

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Carcinoma, Hepatocellular

United States
University of Chicago
Bayer

Completed

Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States
Bayer

Completed

Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety (SORINT)

Carcinoma, Hepatocellular

Germany
Bayer

Completed

Regulatory Post Marketing Surveillance Study on Nexavar®

Carcinoma, Renal Cell | Carcinoma, Hepatocellular

Korea, Republic of
Bayer

Completed

Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan

Carcinoma, Hepatocellular

Japan
Bayer

Completed

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

Belgium, Italy, Spain, Germany, France, Netherlands, Switzerland, Poland, Sweden, United Kingdom, Denmark
Bayer

Terminated

Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Carcinoma, Renal Cell

United States
Bayer

Completed

INSIGHT - Post Marketing Surveillance (INSIGHT)

Carcinoma, Hepatocellular

Germany, Austria
Bayer

Completed

Sorafenib Gastric Cancer Asian Phase I Study

Gastric Cancer

Japan
Bayer
Amgen

Completed

Sorafenib/Docetaxel Dose Escalation Trial

Neoplasms

United States
Ottawa Hospital Research Institute
Bayer

Completed

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Canada
Clinical Research Organization, Dhaka, Bangladesh

Unknown

Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma

Quality of Life

Bangladesh
Far Eastern Memorial Hospital

Completed

Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder (PFMT)

Overactive Bladder

Taiwan
Daewon Pharmaceutical Co., Ltd.

Completed

Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery

Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery
AJU Pharm Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

Hypertension

Korea, Republic of
Bayer

Active, not recruiting

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib (JPMS-DTC)

Thyroid Carcinoma

Japan
Bayer
ICON Clinical Research

Completed

Sorafenib Long Term Extension Program (STEP)

Neoplasms

Spain, Hong Kong, Canada, Germany, France, United States, United Kingdom, Taiwan, New Zealand, Australia, Belgium, China, Bulgaria, Italy, Colombia, Poland, Korea, Republic of, Brazil, Ukraine
Bayer

Completed

Sorafenib for Residue Disease After Resection With Curative Intent (SECURE)

Carcinoma, Hepatocellular

China
Bayer

Completed

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Thyroid Carcinoma

Japan
Bayer

Completed

Sorafenib Dose Escalation in Renal Cell Carcinoma

Carcinoma, Renal Cell

Italy, France, Germany, United Kingdom, Poland
German Breast Group
Bayer

Completed

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer (SOFIA)

Breast Cancer

Germany

Search clinical trials for: Nexavar tab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations